From development to clinical success: the journey of established and next-generation BTK inhibitors.
Saved in:
| Title: | From development to clinical success: the journey of established and next-generation BTK inhibitors. |
|---|---|
| Authors: | Gupta S; Biomolecular Engineering Laboratory, School of Biochemical Engineering, IIT (BHU), Varanasi, 221005, India., Sharma A; Biomolecular Engineering Laboratory, School of Biochemical Engineering, IIT (BHU), Varanasi, 221005, India., Shukla A; Biomolecular Engineering Laboratory, School of Biochemical Engineering, IIT (BHU), Varanasi, 221005, India., Mishra A; Biomolecular Engineering Laboratory, School of Biochemical Engineering, IIT (BHU), Varanasi, 221005, India. abham.bce@itbhu.ac.in., Singh A; Department of Pharmacology, Institute of Medical Science, Banaras Hindu University, Varanasi, 221005, India. amisingh@bhu.ac.in. |
| Source: | Investigational new drugs [Invest New Drugs] 2025 Apr; Vol. 43 (2), pp. 377-393. Date of Electronic Publication: 2025 Feb 27. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
